D-Ribose Aids Heart Health

MINNEAPOLISResults of a study, presented at the 13th World Congress on Heart Disease in Vancouver, British Columbia, suggest supplementation of heart attack off-pump bypass surgery patients with oral D-ribose before surgery may significantly improve cardiac indices. David Perkowski, M.D., chief of Cardiothoracic Surgery at Saddleback Memorial Medical Center, Laguna Hills, Calif., and a study leader, said: Our findings are particularly significant for increasing and maximizing the energy and integrity of the heart. OPCAB with supplemental D-ribose resulted in a 40-percent greater increase in cardiac indices post-operatively compared to the baseline, which has historically demonstrated a 13-percent improvement.

In addition, another research team presented a study at the event showing how D-ribose and folic acid aided right ventricular diastolic function in induced pulmonary hypertension. We found that a combination of D-ribose and folic acid helped hearts stressed by pulmonary hypertension to pump more effectively, said John St. Cyr, M.D., Ph.D., medical director of Bioenergy Life Science, which provided the D-ribose. The right ventricle pumps blood to the lungs and with pulmonary hypertension, the ventricle must work harder. The use of ribose and folic acid benefited these stressed ventricles. Corvalen, which was used in the studies, is a proprietary D-ribose product of Bioenergy Life Science Inc.

For more information, visit www.Bioenergy.com or Booth #24056 at SupplySide West.